Shares of Bio-Techne Corp. rallied 5.67% to $63.03 Monday, on what proved to be an all-around favorable trading session for ...

Instil Bio stock falls after the company ends development of its lead cancer drug and exits a licensing deal, raising new ...

After diving over 17% on January 2, shares in biopharma company Intelligent Bio Solutions ($INBS) are back with a rally, ...

INBS surged on strategic manufacturing partnership and revenue growth, but pulled back after announcing plans to raise $10 ...

Investing.com -- Instil Bio (NASDAQ:TIL) stock fell 15% Tuesday after the company announced that its wholly-owned subsidiary Axion Bio has decided to discontinue clinical development of AXN-2510 and ...

As of Monday, January 05, SAB Biotherapeutics, Inc.’s SABS share price has dipped by 5.57%, which has investors questioning ...

If a little bird told you to think about buying Bluebird Bio (NASDAQ: BLUE) stock recently, there's a lot of information you'll need to evaluate. Between the new product that this small biotech has ...

Bio-Rad Laboratories, Inc. is a multinational manufacturer and distributor of life science research and clinical diagnostics products. The company's stock has been underperforming due to various ...

Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...

Investing.com -- Adicet Bio Inc (NASDAQ:ACET) stock fell 9.2% in premarket trading Friday after the clinical-stage biotechnology company announced a 1-for-16 reverse stock split to regain compliance ...

Bluebird Bio is short on capital and has major new expenses to cover. Meanwhile, its pipeline of drug candidates is looking very weak. Even if it can navigate the next two years, its growth will be ...